Jan 13, 2025 12:50PM
Dec 16, 2024 07:03AM
Dec 2, 2024 06:07AM
Jun 27, 2024 09:51AM
Jun 21, 2024 05:49AM
Jun 21, 2024 04:50AM
Jun 20, 2024 07:23AM RBC Capital Reiterates Outperform Rating on Regenxbio Inc. (RGNX)
Jun 18, 2024 08:43AM
Jun 13, 2024 10:57AM
May 31, 2024 10:23AM
May 28, 2024 05:16AM
May 6, 2024 04:14PM
Apr 4, 2024 04:14PM
Jun 9, 2023 09:58AM Sarepta Therapeutics (SRPT) option implied volatility flat
Jun 8, 2023 10:21AM
Jun 6, 2023 10:08AM
Jun 2, 2023 03:38AM
May 31, 2023 05:04AM
May 30, 2023 10:49AM
May 26, 2023 05:56AM
May 24, 2023 10:52AM Raymond James Stays Sidelined on Sarepta (SRPT) Citing 'heavily eclipsed market opportunity' and 'binary risk heading into EMBARK'
May 24, 2023 09:06AM
May 24, 2023 08:50AM
May 24, 2023 08:48AM
May 23, 2023 04:41AM
May 17, 2023 10:16AM
May 17, 2023 02:05AM
May 16, 2023 10:25AM Sarepta Therapeutics (SRPT) option implied volatility into PDUFA
May 16, 2023 03:59AM
May 15, 2023 11:20AM
May 15, 2023 06:40AM
May 15, 2023 05:37AM
May 12, 2023 07:02PM
Apr 4, 2023 06:21AM
Mar 17, 2023 06:52AM Sarepta (SRPT) sinks 20% as surprise FDA AdComm for SRP-9001 adds risk
Jan 10, 2023 05:43PM
Dec 21, 2022 01:33PM
Dec 16, 2022 08:37AM
Aug 20, 2019 10:16AM
Aug 7, 2019 05:38PM
Aug 7, 2019 04:05PM
May 10, 2019 08:47AM Sarepta Therapeutics (SRPT) Buy Rating Reiterated At Needham After Exondys Sales Guidance Is Maintained
Apr 8, 2019 06:53AM
Feb 27, 2019 04:05PM
Oct 2, 2017 09:32AM
Mar 1, 2017 09:24AM
Feb 28, 2017 06:03PM
Aug 3, 2016 10:28AM
Jul 19, 2016 04:00PM Sarepta Therapeutics Announces Second Quarter 2016 Financial Results and Recent Corporate Developments
Jun 7, 2016 09:08AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All